Literature DB >> 20410441

Differential association modes of the thrombin receptor PAR1 with Galphai1, Galpha12, and beta-arrestin 1.

Mohammed Akli Ayoub1, Eric Trinquet, Kevin D G Pfleger, Jean-Philippe Pin.   

Abstract

Although many G protein-coupled receptors (GPCRs) are known to activate multiple signaling pathways by coupling to different types of G proteins or by promoting G protein-independent events, how this occurs remains unclear. Using bioluminescence resonance energy transfer and time-resolved fluorescence resonance energy transfer, we provide evidence for protease-activated receptor 1 (PAR(1)) forming preassembled complexes with Galphai1 but not Galpha12. PAR(1) activation appears to rapidly induce transient Galphai1 activation (t(1/2) = 4.13 s) but late and stable recruitment of Galpha12 (t(1/2) = 8.8 min) in parallel with beta-arrestin 1 (t(1/2) = 7.5 min). However, there is no significant difference in the potency of the agonist-dependent response between Galphai1, Galpha12, and beta-arrestin 1 (EC(50) values 0.48, 0.30, and 0.15 nM, respectively). Although it seems beta-arrestin 1 is recruited to preassembled PAR(1)-Galphai1 complexes, this appears unlikely with Galpha12, suggesting 2 distinct receptor populations. Of note, we observed a different Galpha12 association mode with other GPCRs, indicating that preassembly and association dynamics may be specific properties of a receptor-G protein pair. Furthermore, the Galpha C terminus appears to play different roles in the distinct association modes. Consequently, G protein preassembly or recruitment may constitute novel mechanisms for controlling the kinetics and multitude of GPCR signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20410441     DOI: 10.1096/fj.10-154997

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  28 in total

Review 1.  Probing heterotrimeric G protein activation: applications to biased ligands.

Authors:  Colette Denis; Aude Saulière; Segolene Galandrin; Jean-Michel Sénard; Céline Galés
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes.

Authors:  Marta Busnelli; Aude Saulière; Maurice Manning; Michel Bouvier; Celine Galés; Bice Chini
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

Review 3.  Protease-activated receptors in hemostasis.

Authors:  Marvin T Nieman
Journal:  Blood       Date:  2016-04-28       Impact factor: 22.113

4.  Neutrophil elastase and proteinase-3 trigger G protein-biased signaling through proteinase-activated receptor-1 (PAR1).

Authors:  Koichiro Mihara; Rithwik Ramachandran; Bernard Renaux; Mahmoud Saifeddine; Morley D Hollenberg
Journal:  J Biol Chem       Date:  2013-09-19       Impact factor: 5.157

Review 5.  Heterotrimeric G proteins, focal adhesion kinase, and endothelial barrier function.

Authors:  Tracy Thennes; Dolly Mehta
Journal:  Microvasc Res       Date:  2011-05-20       Impact factor: 3.514

Review 6.  Allosteric modulation of protease-activated receptor signaling.

Authors:  I Canto; U J K Soh; J Trejo
Journal:  Mini Rev Med Chem       Date:  2012-08       Impact factor: 3.862

Review 7.  Targeting PAR1: Now What?

Authors:  Robert Flaumenhaft; Karen De Ceunynck
Journal:  Trends Pharmacol Sci       Date:  2017-05-27       Impact factor: 14.819

8.  Modulation of PAR(1) signalling by benzimidazole compounds.

Authors:  S Asteriti; S Daniele; F Porchia; M T Dell'Anno; A Fazzini; I Pugliesi; M L Trincavelli; S Taliani; C Martini; M R Mazzoni; A Gilchrist
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

9.  Novel role of proline-rich nonreceptor tyrosine kinase 2 in vascular wall remodeling after balloon injury.

Authors:  Ravisekhar Gadepalli; Nikhlesh K Singh; Venkatesh Kundumani-Sridharan; Mark R Heckle; Gadiparthi N Rao
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-08-23       Impact factor: 8.311

Review 10.  Matrix metalloproteases and PAR1 activation.

Authors:  Karyn M Austin; Lidija Covic; Athan Kuliopulos
Journal:  Blood       Date:  2012-10-18       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.